COVID-19 vaccine race: Spotlight on Pfizer, Moderna as trial data to be released soon1 min read 06 Oct 2020, 04:21 PM IST
Moderna's COVID-19 vaccine has produced a strong immune response in older adults with no serious adverse effects during phase I trial, shows study
Pfizer’s coronavirus vaccine could be distributed before the end of the year if found to be safe and effective, CEO said
Two vaccine makers — Moderna and Pfizer — should have enough data from its late-stage trial to know whether its coronavirus vaccine works by next month, according to reports.
Select your Category